Mark Mercola

Stanford University, Palo Alto, CA 
"Mark Mercola"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bruyneel AAN, Colas AR, Karakikes I, et al. (2019) AlleleProfileR: A versatile tool to identify and profile sequence variants in edited genomes. Plos One. 14: e0226694
Halver J, Wenzel K, Sendker J, et al. (2019) Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn? Frontiers in Pharmacology. 10: 1357
Hurtado C, Safarova A, Smith M, et al. (2019) Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ. Scientific Reports. 9: 10811
Fang MY, Markmiller S, Vu AQ, et al. (2019) Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD. Neuron
Hnatiuk A, Mercola M. (2019) Stars in the Night Sky: iPSC-Cardiomyocytes Return the Patient Context to Drug Screening. Cell Stem Cell. 24: 506-507
Seeger T, Shrestha R, Lam CK, et al. (2018) A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay. Circulation
Sharma A, McKeithan WL, Serrano R, et al. (2018) Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity. Nature Protocols
Gómez-Galeno JE, Hurtado C, Cheng J, et al. (2018) b-Annulated 1,4-dihydropyridines as Notch inhibitors. Bioorganic & Medicinal Chemistry Letters
Bruyneel AA, McKeithan WL, Feyen DA, et al. (2018) Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease? Current Opinion in Pharmacology. 42: 55-61
Okolotowicz KJ, Dwyer M, Ryan D, et al. (2018) Novel tertiary sulfonamides as potent anti-cancer agents. Bioorganic & Medicinal Chemistry
See more...